Диасек

Quick links

Choose a section

Quick links to important sections

Advertisements

Диасек

Selected form

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Диасек

What is Diasec? Overview

Property Description
Active Ingredient Diosmectite (purified natural clay)
Form Oral Powder or Capsules (for suspension)
Pharmacological Class Intestinal Adsorbent / Antidiarrheal Agent
Common Therapeutic Use Symptomatic treatment of acute and chronic diarrhea
Origin Natural (aluminomagnesium silicate clay)

What is Diasec and what is it generally used for?

Diasec, with its active ingredient Diosmectite, is a locally acting gastrointestinal medicine primarily used as an adsorbent antidiarrheal agent to help restore healthy gut balance during episodes of diarrhea. It is typically supplied as an Over-the-Counter (OTC) oral powder or capsules designed for administration, where its active component acts strictly within the digestive tract.

Its general therapeutic purpose is the symptomatic relief of acute, non-specific diarrhea, addressing issues such as increased frequency and watery stools. The use of adsorbent agents for this purpose provides essential supportive care by physically controlling the contents of the intestine.

Diasec Composition: Natural Origin and Pharmacological Class

The active ingredient in Diasec is Diosmectite, a purified, natural aluminomagnesium silicate clay. It is classified as an Intestinal Adsorbent agent due to its highly layered physical structure, which grants it a high binding capacity within the gut lumen, allowing it to act without being absorbed into the body.

This agent is notable for its natural origin and its dual function: it physically binds to toxins and water, and simultaneously creates a protective physical barrier along the intestinal lining. Diosmectite is characterized as a mucus stabilizer and cytoprotector of the gastrointestinal lining. This non-systemic, physical mode of action is central to its role in regulating the movement of intestinal contents and achieving stool firming.

Advertisements

What side effects are possible with Диасек?

Possible Side Effects and Safety Information

The safety profile of Diasec (Diosmectite) is primarily characterized by effects that occur locally within the gastrointestinal tract, consistent with its non-systemic mode of action. All documented adverse reactions and safety constraints are classified and published in official regulatory documents, such as the Summary of Product Characteristics (SmPC) and FDA-aligned labels.


Frequency-Classified Adverse Reactions

The incidence of possible side effects is formally categorized based on regulatory standards:

  • Common (1/100): The most frequently reported adverse reaction is constipation. Official safety guidance notes that if constipation develops, the effect is managed by reducing the daily dose or temporarily stopping treatment.
  • Uncommon (1/1,000): This frequency class includes documented effects such as vomiting and rash.
  • Unknown Frequency: Reactions related to the immune system, such as hypersensitivity (including angioedema), urticaria (hives), and pruritus, are also listed in official documentation.

Safety Restrictions and Limitations

Specific constraints on use are explicitly defined in regulatory documents:

  • Population Restrictions: Diasec must be avoided in children under 2 years of age. Use is also not recommended for pregnant or lactating women due to insufficient safety data in these groups.
  • Interaction Risk: Due to its adsorbent properties, this agent may interfere with the absorption of other orally administered medicinal products. Official documents require that other medicines be taken separately, usually with a time interval of at least two hours.
  • Chronic Use: Official safety advice recommends avoiding the long-term or chronic use of this product.

The overall safety framework is structured around managing the local effects, such as constipation, and adhering to restrictions for vulnerable populations and concurrent medication use.

Advertisements

Overdose and Emergency Response

Overdose Manifestations and Required Actions

The official regulatory profile for Diasec (Diosmectite) indicates that because the active ingredient is a non-systemic intestinal adsorbent, its overdose potential is strictly localized to the gastrointestinal tract. Regulatory labeling explicitly confirms there is no evidence of systemic toxicity, such as neurological or cardiovascular effects, following an overdosage event.

The primary clinical manifestation documented is the exacerbation of the drug’s physical effect, resulting in severe constipation. The most serious, though rare, outcome documented is the potential for a physical blockage: intestinal obstruction or bezoar formation. This severe manifestation is a particular concern in the pediatric population.

Required Actions and Management Regulatory Statement
Immediate Action Treatment must be stopped immediately upon the first suspicion of overdosage.
Urgent Medical Help Seek immediate medical attention is required for any overdose event, particularly if severe constipation or signs of intestinal obstruction are present.
Management Protocol Management is limited to symptomatic treatment only. No specific antidote is known due to the drug's non-systemic nature.
Monitoring Hospital monitoring may be required for professional evaluation of severe gastrointestinal symptoms or potential obstruction.

Summary of Overdose Profile

The regulatory guidance defines the overdose profile based entirely on the drug's physical effects, rather than systemic toxicity. This dictates that the key trigger for seeking help is the development of severe, localized gastrointestinal symptoms, which ensures appropriate medical oversight for the rare, localized risk of intestinal obstruction.

Advertisements

Therapeutic Uses of Диасек

What Diasec Treats: Main Uses and Benefits

Diasec (Diosmectite) is commonly used to help with symptoms related to heightened physiological activity in the gut, which manifests as acute diarrheal episodes. As such, the medication is utilized as part of symptomatic management for acute diarrhea in both adult and pediatric populations.


This agent is relevant for easing physical symptom clusters that create noticeable physiological strain. It is specifically applied in clinical settings that involve acute or unstable symptom patterns, and is considered relevant for symptomatic assistance in conditions involving episodic or fluctuating manifestations, including chronic functional diarrhea and the symptomatic component of Irritable Bowel Syndrome (IBS-D).

The medication is commonly used to help with symptoms that interfere with daily functioning, including the increased frequency of evacuations, watery stools, and associated gastrointestinal discomfort.

“Symptomatic management contributes to improved comfort during periods of heightened symptoms.”

This symptomatic assistance provides support that helps ease the overall symptom burden and assists with maintaining functional stability when symptoms become more noticeable.

Quick Fact: Relief for Diarrheal Symptoms
This medication is commonly used when short-term symptomatic assistance is needed for managing symptoms related to the frequency and consistency of loose stools.

Regulatory References

  1. French National Health Authority
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Диасек — official regulatory information

The eligibility for using Diasec (Diosmectite) is strictly defined by regulatory authorities based on age, physiological status, and underlying clinical conditions. This information outlines the patient groups for whom the medicine is permitted, restricted, or absolutely prohibited from use.


Eligibility Scope

Eligibility Scope Official Regulatory Status
Populations Allowed Adults and Children 2 years of age and above with acute diarrhea.
Populations Contraindicated Patients with known hypersensitivity to Diosmectite or any excipient.
Age-Related Restrictions Use is not recommended in children under 2 years of age as a precautionary measure.
Physiological Restrictions Use is not recommended for pregnant or breastfeeding women due to a lack of sufficient data.
Condition-Specific Restrictions Exclusion applies to patients with alarm symptoms of diarrhea (e.g., bloody stool, fever, severe dehydration) and those with a history of inflammatory bowel disease or severe digestive malabsorption.
Advertisements

What should I know about interactions with other medicines?

Diasec (loperamide) is generally safe when taken as directed, but it can interact with various other medicines and substances. These interactions can potentially increase the level of loperamide in the blood, raising the risk of serious side effects, including cardiac events like abnormal heart rhythms (QT prolongation).

It is essential to consult a healthcare professional about all current medications, including prescription, over-the-counter (OTC) drugs, vitamins, and herbal products.

Medicines that May Interact with Диасек

Drug Class or Specific Drug Potential Interaction Outcome
HIV Medications Ritonavir may increase loperamide concentration
Antifungal Agents Itraconazole, Ketoconazole may increase loperamide concentration
Cholesterol-Lowering Drugs Gemfibrozil may increase loperamide concentration
Drugs Affecting Heart Rhythm Quinidine, Amiodarone, Sotalol may increase the risk of QT prolongation
Certain Antibiotics Erythromycin, Clarithromycin may increase loperamide concentration or risk of QT prolongation
Other Medications Desmopressin (for excessive urination), certain Antidepressants, and Antipsychotics may also interact.

Taking multiple medications that slow down the gut's motility can increase the risk of severe constipation or serious bowel complications. Additionally, consuming grapefruit juice can potentially increase loperamide levels. Always discuss any potential combinations with a pharmacist or doctor to minimize risks.

Advertisements

Mechanism of Action

Selective Enzyme Inhibition in the Intestine

The drug's active form functions as a specific, selective competitive inhibitor of the enzyme Neutral Endopeptidase (NEP), which is situated on the brush border of intestinal enterocytes. This targeted inhibition prevents the rapid breakdown of endogenous opioid peptides (enkephalins), increasing their local concentration within the intestinal pathway.

Modulating Fluid and Electrolyte Transport

Elevated local levels of natural signaling peptides (enkephalins) activate delta-opioid receptors on the intestinal cells. This receptor activation mediates a reduction in the release of chloride ions and, consequently, water into the gut lumen. This mechanism is peripheral and focused entirely on the shift in the ratio of fluid secretion to absorption, a key physiological consequence of the drug's action. The mechanism alters the volume and liquidity of the intestinal contents without influencing the rate of intestinal motility.

Advertisements

Dosage and Administration Information

The official instructions for using Диасек (diazepam rectal gel) govern the precise dose calculation, administration procedure, and frequency limits.

Administration Scope

Instruction Entity General Guidelines
Route of Administration Rectal administration only (via prefilled, unit-dose rectal delivery system).
Dosing Schedule Individualized based on age and body weight, then rounded up to the nearest available unit-dose syringe strength.
Age-Group Rules Ages 2–5 years: 0.5 mg/kg
Ages 6–11 years: 0.3 mg/kg
Ages 12 years and older: 0.2 mg/kg
Timing in Relation to Meals Not applicable (rectal administration).

Frequency and Procedural Requirements

Frequency Constraints: The drug is for acute, intermittent use only. No more than two doses may be given per episode. If a second dose is needed, it must be given 4 to 12 hours after the first dose. Treatment frequency must not exceed one episode every five days or five episodes per month.

Preparation Requirements: Before use, the prescribed dose must be confirmed via the display window (AcuDial) and the syringe tip must be lubricated.

Official Step Sequence (Caregiver Protocol):

  • Remove the cap, ensuring the seal pin is removed. Lubricate the rectal tip.
  • Position the person on their side and gently insert the syringe tip into the rectum until the rim is snug.
  • Slowly count to 3 while pushing the plunger in until it stops.
  • Slowly count to 3 before removing the syringe from the rectum.
  • Slowly count to 3 while holding the buttocks together to prevent leakage.

Connection to the Overall Use Protocol:

The official usage instructions define a strictly controlled protocol for this intermittent medication, linking a precise weight-based dose to a detailed, mandatory administration sequence. These steps, including frequency and timing constraints, ensure the drug is used solely for the intended acute purpose and not for chronic, daily management.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Диасек


Evidence from Clinical Trials for Acute Diarrhea

The primary research for Диасек (Diosmectite) has explored its use in short-term, sudden onset diarrhea. This evidence mainly comes from short-term Randomized Controlled Trials (RCTs) and subsequent Meta-analyses. These studies primarily focused on populations of children (including infants over one month of age) and adults experiencing non-specific, acute episodes. Researchers explored outcomes such as the time it took for the patient to pass the first formed stool (time to recovery) and the overall change in stool output during the study period. Studies monitored the duration of the diarrheal episode compared to those receiving a placebo, reporting measured changes in stool frequency and consistency. However, certainty remains low in some aggregated analyses due to study design variations.

Evidence for Chronic and Functional Diarrhea

Research examined the application of Диасек in conditions characterized by fluctuating or episodic manifestations, such as chronic functional diarrhea and the symptomatic component of Irritable Bowel Syndrome (IBS-D). This research was conducted using medium-term RCTs and observational settings in adults. Researchers monitored patient-reported outcomes including bowel movement frequency and gastrointestinal discomfort. Findings varied across trials, with studies reporting how symptoms evolved in the observed populations.

Research Gaps and Areas of Uncertainty

A key limitation is that follow-up durations were limited (often only a few weeks) relative to the chronic nature of the conditions, meaning long-term effects are not fully established regarding functional outcomes. Data for certain groups remain insufficient, and sample sizes were modest in many exploratory trials. The results apply only to the populations studied, and existing studies provide limited insight into the agent’s effects on severe outcomes like hospitalization.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Диасек (FAQ)


Q: Does taking Диасек for a long time change how it works?

Official safety advice strongly recommends avoiding the long-term or chronic use of this product. The mechanism of action, which involves the physical adsorption of substances in the gut, does not involve absorption into the bloodstream. Safety advice is limited to short-term use, and long-term effects on the gut environment are not fully described in official documents.


Q: Does Диасек affect the results of common lab tests?

While there is no specific official guidance about interference with routine lab tests, the drug's absorbent properties are known to interfere with the absorption of other orally administered medicinal products. Official documents recommend separating the administration of Диасек from other medicines by at least two hours. One regulatory body has noted the need for particular caution in specific groups, which underlies the restriction against use in children under 2 years of age.


Q: Can Диасек be taken with vitamin supplements or herbal remedies?

Yes, but they must be taken separately. Due to its adsorbent properties, Диасек may interfere with the body's absorption of other orally administered substances, including vitamin supplements and herbal remedies. Official documentation requires that these products be taken with a time interval of at least two hours before or after Диасек.


Q: Is Диасек considered safe for long-term use, based on regulatory information?

Official safety advice does not recommend long-term use. It is intended for short-term, symptomatic relief of diarrhea episodes, and its long-term safety profile is not fully established in regulatory documents.


Q: Can I combine Диасек with other prescription medicines without checking for interactions?

Official guidelines recommend caution regarding combination with other medicines. Due to its absorbent nature, there is a potential for Диасек to interfere with the absorption of co-administered medicines, reducing their effectiveness. Regulatory guidance requires that all other oral medicines are administered separately (at least two hours apart).


Q: Does Диасек require special monitoring while being used?

Official documents do not typically require specialized laboratory monitoring. However, the label advises stopping treatment if severe constipation occurs. Furthermore, regulatory guidance for use in children requires the early administration of an Oral Rehydration Solution (ORS) to prevent dehydration.


Q: Does the effectiveness of Диасек change over time?

Studies have mainly focused on short-term use for acute conditions. Because follow-up in clinical research was limited, long-term effects and changes in effectiveness over extended periods are not fully established in the official data. The product is not recommended for chronic use.


Q: Is it necessary to finish the entire course of Диасек, even if I feel better?

Диасек is indicated for the symptomatic treatment of diarrhea. If constipation develops, official guidance is to manage the effect by reducing the dose or temporarily stopping treatment. This suggests that use is tied to managing symptoms.


Q: What should I do if I think I'm experiencing a rare side effect from Диасек?

Official documents list potential adverse reactions like hypersensitivity, which is of unknown frequency. Official documents advise that any suspected adverse drug reaction should be reported to the national regulatory health authority or the product manufacturer.


Q: Does Диасек affect sleep patterns?

Changes in sleep patterns are not listed among the formally classified adverse reactions (Common, Uncommon, or Unknown Frequency) in the official regulatory summaries for this product.


Q: Is Диасек used only for the conditions listed on the label?

The drug is officially authorized and indicated only for the symptomatic treatment of acute and chronic diarrhea as described in regulatory documents. Any use for conditions not listed on the official label is not supported by the regulatory documents.


Q: How quickly should I expect to see the effects of Диасек?

In studies of acute diarrhea, measured outcomes like the reduction in frequency of bowel motions were typically observed after approximately two days of treatment in the studied populations. Time to first formed stool is an outcome measured in research.


Q: What does 'contraindicated' mean in relation to Диасек?

'Contraindicated' refers to a specific condition or circumstance where the official regulatory documents strictly state that the drug must not be used. For Диасек, examples include known hypersensitivity to the active substance and and age under two years.


Q: Are there any known issues with taking Диасек and having an alcoholic beverage?

Official documents describe the presence of small amounts of alcohol as an excipient in some formulations. However, the official interactions section does not list co-consumption with alcoholic beverages as a specific interaction issue.


Q: Is there a maximum time frame that a person is usually advised to take Диасек?

Official guidelines for acute diarrhea in adults recommend treatment for approximately seven days. Although short-term studies have sometimes used the drug for longer periods, regulatory advice emphasizes avoiding chronic use.


Q: Is it normal to have certain mild, temporary side effects when first starting Диасек?

Official documents list constipation as a Common adverse reaction, meaning it is one of the most frequently reported effects, particularly when starting treatment. This reaction is managed by dose reduction or temporary cessation of use.


Q: How should Диасек generally be stored?

Official labeling requires Диасек to be stored at controlled room temperature (typically 20 C to 25 C). It must be kept in its original container to protect it from light and moisture, and it must always be kept out of the sight and reach of children.


Q: Can Диасек interact with common over-the-counter pain relievers?

Yes. The adsorbent properties of Диасек can interfere with the absorption of any orally administered medicinal product, including over-the-counter pain relievers. All other oral medicines must be taken separately, with at least a two-hour interval.


Q: Is Диасек prescribed for conditions other than the primary one it treats?

The official authorized uses for Диасек are strictly defined in regulatory labeling as the symptomatic treatment of acute and chronic diarrhea. Use for any other condition is not described or supported by the official regulatory documents.


Q: Is the onset of action of Диасек affected by food intake?

Official documentation for some formulations advises that the drug be taken away from meals for diarrhea indications. This is related to the drug's physical mechanism of action as a gut adsorbent.


Q: Are there different strengths or formulations of Диасек?

Yes. Regulatory documents confirm that Диасек (Diosmectite) is typically available as a powder for oral suspension in sachets, often containing 3g of the active substance.


Q: Why is the information for Диасек often listed under a different chemical name?

The product is marketed under its brand or trade name, Диасек. However, the medicine's technical and regulatory information is standardly listed under the chemical name of the active ingredient, Diosmectite.


Q: What should I do if I suspect an overdose of Диасек?

Official regulatory information on overdosage states that the risk of severe constipation is generally increased. The official protocol for suspected overdose is to seek immediate medical attention and contact a poison control center.


Q: What is the half-life of Диасек?

The active ingredient, Diosmectite, is a locally acting adsorbent that is not absorbed into the bloodstream. Because it remains confined to the gut lumen, it does not have a measurable systemic half-life like medicines that circulate throughout the body.


Q: Does the regulatory body require specific warnings for Диасек?

Yes. Regulatory documents require specific warnings, including the need for caution in patients with a history of severe chronic constipation, the requirement to avoid chronic use, and the necessity of using the drug with oral rehydration solution in children.


Q: What are the non-drug ways mentioned in official documents to manage the condition treated by Диасек?

Official documents and guidelines for managing acute diarrhea, especially in children, emphasize that the most critical supportive treatment is the use of oral rehydration solution (ORS). This is necessary to prevent or treat dehydration that can accompany diarrhea.

Advertisements

How should Диасек be stored and disposed of?

How to Store and Dispose of Диасек?

Диасек must be stored under specific conditions to maintain its effectiveness. Official labeling requires storage at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C (86 F). The product must be kept in its original container to protect it from light and moisture.

It is essential to protect the medication from freezing and excessive heat. Any use beyond the officially defined stability period after opening or reconstitution must be avoided.

For disposal, do not flush unused or expired Диасек down a toilet or pour it down a drain unless explicitly instructed by a governmental regulation. All disposal must follow local, state, and federal guidelines for pharmaceutical waste. The product must be kept out of the sight and reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Диасек found in:

A-Z Index: